PURPOSE: As one solution to reducing costs and medical bankruptcies, experts have suggested that patients and physicians should discuss the cost of care up front. Whether these discussions are possible in an oncology setting and what their effects on the doctor-patient relationship are is not known. METHODS: We used the National Comprehensive Cancer Network (NCCN) Guidelines and the eviti Advisor platform to show patients with metastatic breast, lung, or colorectal cancer the costs associated with their chemotherapy and/or targeted therapy options during an oncology consultation. We measured provider attitudes and assessed patient satisfaction when consultations included discussion of costs. RESULTS: We approached 107 patients; 96 (90%) enrolled onto the study, three (3%) asked if they could be interviewed at a later date, and eight (7%) did not want to participate. Only five of 18 oncologists (28%) felt comfortable discussing costs, and only one of 18 (6%) regularly asked patients about financial difficulties. The majority of patients (80%) wanted cost information, and 84% reported that these conversations would be even more important if their co-pays were to increase. In total, 72% of patients responded that no health care professional has ever discussed costs with them. The majority of patients (80%) had no negative feelings about hearing cost information. CONCLUSION: In an era of rising co-pays, patients with cancer want cost-of-treatment discussions, and these conversations do not lead to negative feelings in the majority of patients. Additional training to prepare clinicians for how to discuss costs with their patients is needed.
PURPOSE: As one solution to reducing costs and medical bankruptcies, experts have suggested that patients and physicians should discuss the cost of care up front. Whether these discussions are possible in an oncology setting and what their effects on the doctor-patient relationship are is not known. METHODS: We used the National Comprehensive Cancer Network (NCCN) Guidelines and the eviti Advisor platform to show patients with metastatic breast, lung, or colorectal cancer the costs associated with their chemotherapy and/or targeted therapy options during an oncology consultation. We measured provider attitudes and assessed patient satisfaction when consultations included discussion of costs. RESULTS: We approached 107 patients; 96 (90%) enrolled onto the study, three (3%) asked if they could be interviewed at a later date, and eight (7%) did not want to participate. Only five of 18 oncologists (28%) felt comfortable discussing costs, and only one of 18 (6%) regularly asked patients about financial difficulties. The majority of patients (80%) wanted cost information, and 84% reported that these conversations would be even more important if their co-pays were to increase. In total, 72% of patients responded that no health care professional has ever discussed costs with them. The majority of patients (80%) had no negative feelings about hearing cost information. CONCLUSION: In an era of rising co-pays, patients with cancer want cost-of-treatment discussions, and these conversations do not lead to negative feelings in the majority of patients. Additional training to prepare clinicians for how to discuss costs with their patients is needed.
Authors: M Holmes-Rovner; J Kroll; N Schmitt; D R Rovner; M L Breer; M L Rothert; G Padonu; G Talarczyk Journal: Med Decis Making Date: 1996 Jan-Mar Impact factor: 2.583
Authors: M Tamburini; L Gangeri; C Brunelli; E Beltrami; P Boeri; C Borreani; C Fusco Karmann; M Greco; G Miccinesi; L Murru; P Trimigno Journal: Ann Oncol Date: 2000-01 Impact factor: 32.976
Authors: Jonathan R McDonagh; Tricia B Elliott; Ruth A Engelberg; Patsy D Treece; Sarah E Shannon; Gordon D Rubenfeld; Donald L Patrick; J Randall Curtis Journal: Crit Care Med Date: 2004-07 Impact factor: 7.598
Authors: Michael T Halpern; Elizabeth M Ward; Alexandre L Pavluck; Nicole M Schrag; John Bian; Amy Y Chen Journal: Lancet Oncol Date: 2008-02-20 Impact factor: 41.316
Authors: Elizabeth Ward; Michael Halpern; Nicole Schrag; Vilma Cokkinides; Carol DeSantis; Priti Bandi; Rebecca Siegel; Andrew Stewart; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2007-12-20 Impact factor: 508.702
Authors: Sharon M Parker; Josephine M Clayton; Karen Hancock; Sharon Walder; Phyllis N Butow; Sue Carrick; David Currow; Davina Ghersi; Paul Glare; Rebecca Hagerty; Martin H N Tattersall Journal: J Pain Symptom Manage Date: 2007-05-25 Impact factor: 3.612
Authors: Giselle K Perez; John M Salsman; Kaitlyn Fladeboe; Anne C Kirchhoff; Elyse R Park; Abby R Rosenberg Journal: Am Soc Clin Oncol Educ Book Date: 2020-03
Authors: Theresa A Hastert; Jaclyn M Kyko; Amanda R Reed; Felicity W K Harper; Jennifer L Beebe-Dimmer; Tara E Baird; Ann G Schwartz Journal: Cancer Epidemiol Biomarkers Prev Date: 2019-05-06 Impact factor: 4.254
Authors: Neli Slavova-Azmanova; Jade C Newton; Harry Hohnen; Claire E Johnson; Christobel Saunders Journal: Support Care Cancer Date: 2019-03-29 Impact factor: 3.603
Authors: Mary C Politi; Rachel L Grant; Nerissa P George; Abigail R Barker; Aimee S James; Lindsay M Kuroki; Timothy D McBride; Jingxia Liu; Courtney M Goodwin Journal: Oncologist Date: 2020-02-28
Authors: Ryan D Nipp; Amy M Shui; Giselle K Perez; Anne C Kirchhoff; Jeffrey M Peppercorn; Beverly Moy; Karen Kuhlthau; Elyse R Park Journal: JAMA Oncol Date: 2018-06-01 Impact factor: 31.777